Chimera Investment Corporation  

(Public, NYSE:CIM)   Watch this stock  
Find more results for CIM
+0.26 (1.38%)
Dec 15 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 18.93 - 19.28
52 week 16.67 - 20.90
Open 18.96
Vol / Avg. 1.54M/903,335.00
Mkt cap 3.60B
P/E 5.89
Div/yield 0.50/10.44
EPS 3.25
Shares 187.78M
Beta 0.91
Inst. own 53%
Feb 12, 2018
Q4 2017 Chimera Investment Corp Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Nov 2, 2017
Q3 2017 Chimera Investment Corp Earnings Release
Nov 2, 2017
Q3 2017 Chimera Investment Corp Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin 46.91% 57.96%
Operating margin 46.91% 57.97%
EBITD margin - 63.68%
Return on average assets 2.66% 3.45%
Return on average equity 14.42% 18.11%
Employees 38 -
CDP Score - -


520 Madison Ave Fl 32
NEW YORK, NY 10022-4213
United States - Map
+1-212-6262300 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Chimera Investment Corporation is a real estate investment trust (REIT). The company is engaged in the business of investing in a portfolio of mortgage assets, including agency residential mortgage-backed security (RMBS), non-agency RMBS, agency commercial mortgage-backed securities (CMBS), residential mortgage loans and real estate related securities. The Company's objective is to provide risk-adjusted returns to its investors over the long-term, primarily through dividends and secondarily through capital appreciation. The Company focuses to achieve this objective by investing in an investment portfolio of RMBS, agency CMBS, residential mortgage loans, commercial mortgage loans, real estate-related securities and various other asset classes. The MBS and real estate-related securities the Company purchases include investment-grade and non-investment grade classes, including the BB-rated, B-rated and non-rated classes. It also invests in investment grade and non-investment grade RMBS.

Officers and directors

Matthew Lambiase President, Chief Executive Officer, Director
Age: 51
Bio & Compensation  - Reuters
Robert S. Colligan Chief Financial Officer
Age: 46
Bio & Compensation  - Reuters
Choudhary Yarlagadda Chief Operating Officer
Age: 55
Bio & Compensation  - Reuters
Mohit Marria Chief Investment Officer
Age: 39
Bio & Compensation  - Reuters
Phillip John Kardis II Chief Legal Officer ,Secretary
Age: 55
Bio & Compensation  - Reuters
Paul Donlin Non-Executive Independent Chairman of the Board
Age: 55
Bio & Compensation  - Reuters
Mark Abrams Independent Director
Age: 68
Bio & Compensation  - Reuters
Teresa Bryce Bazemore Independent Director
Age: 57
Bio & Compensation  - Reuters
Gerard Creagh Independent Director
Age: 59
Bio & Compensation  - Reuters
Paul A. Keenan Independent Director
Age: 50
Bio & Compensation  - Reuters